Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Events>This Event
  Events - September 2012


2nd Neuropsychiatric Research and Development

13 Sep 2012 - 14 Sep 2012 - San Fracisco, CA, Hilton San Francisco Financial District



Bookmark and Share


The last decade has seen an impressive dissolution of the thin line dividing neurologic and psychiatric disorders. Today, the fields of neuropsychiatry and behavioral neurology are two of the fastest growing and are most vigorously researched specialties in the medical arena. The past year has seen an incredible increase in the elucidation of both the biological and functional underpinnings of numerous neuropsychiatric conditions, including depression, anxiety disorders, aging-associated diseases, and degenerative diseases. With increased access to imaging and analytic techniques, novel on- and off-label treatment options are emerging on a near-monthly basis.

GTC is proud to host our inaugural 2nd Neuropsychiatric Research and Development to be held September 13-14, 2012 inSan Francisco, CA. This conference will update practitioners in psychiatry, neurology, and primary care on the latest in neuropsychiatric theory and practice. Through a series of presentations led by industry leaders from the fields of medical research, academic research, pharmaceutical development, and biotech engineering, we will supply attendees with the latest developments in neuropsychiatric pathologies, epidemiologies, and treatment options. This conference will provide a forum for intimate discourse that can lead to increased benefits for clients and patients suffering from a number of prominent disorders. 



Further information
Scientific News
The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
LaVision BioTec Reports on the Neuro Research on the Human Brain After Trauma
Company reports on the work of Dr Ali Ertürk from the Institute for Stroke and Dementia Research at LMU Munich.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
Less May Be More in Slowing Cholera Epidemics
Mathematical model shows more cases may be prevented and more lives saved when using one dose of cholera vaccine instead of recommended two doses.
Investigating the Vape
Expert independent review concludes that e-cigarettes have potential to help smokers quit.
NIH Launches Human RSV Study
Study aims to understand infection in healthy adults to aid development of RSV medicines, vaccines.
Researchers Discover Synthesis of a New Nanomaterial
Interdisciplinary team creates biocomposite for first time using physiological conditions.
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
Flu Remedies Help Combat E. coli Bacteria
Physiologists from the University of Zurich have now discovered why the intestinal bacterium Escherichia coli (E. coli) multiplies heavily and has an inflammatory effect.
Marijuana Genome Unraveled
A study by Canadian researchers is providing a clearer picture of the evolutionary history and genetic organization of cannabis, a step that could have agricultural, medical and legal implications for this valuable crop.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!